Stock Scorecard
Stock Summary for Utah Medical Products Inc (UTMD) - $67.16 as of 4/25/2024 2:02:57 PM EST
Total Score
18 out of 29
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for UTMD
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for UTMD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for UTMD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for UTMD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for UTMD
Financial Details for UTMD
Company Overview |
|
|---|---|
| Ticker | UTMD |
| Company Name | Utah Medical Products Inc |
| Country | USA |
| Description | Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 4/24/2024 |
Stock Price History |
|
| Last Day Price | 67.16 |
| Last Day Price Updated | 4/25/2024 2:02:57 PM EST |
| Last Day Volume | 25,241 |
| Average Daily Volume | 31,641 |
| 52-Week High | 99.16 |
| 52-Week Low | 66.17 |
| Last Price to 52 Week Low | 1.50% |
Valuation Measures |
|
| Trailing PE | 14.70 |
| Industry PE | 48.36 |
| Sector PE | 61.73 |
| 5-Year Average PE | 15.81 |
| Free Cash Flow Ratio | 2.60 |
| Industry Free Cash Flow Ratio | 61.97 |
| Sector Free Cash Flow Ratio | 30.74 |
| Current Ratio Most Recent Quarter | 22.56 |
| Total Cash Per Share | 25.88 |
| Book Value Per Share Most Recent Quarter | 35.35 |
| Price to Book Ratio | 1.92 |
| Industry Price to Book Ratio | 5.21 |
| Sector Price to Book Ratio | 22.08 |
| Price to Sales Ratio Twelve Trailing Months | 4.91 |
| Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
| Total Shares Outstanding | 3,589,000 |
| Market Capitalization | 241,037,240 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 3/14/2024 |
| Last Dividend Amount | 0.30 |
| Current Dividend Amount | 0.30 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 1.19 |
| Trailing Annual Dividend Yield | 1.75% |
| Forward Annual Dividend Rate | 1.21 |
| Forward Annual Dividend Yield | 1.78% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 1.81% |
| 5-Year Average Dividend Yield | 1.56% |
| 1-Year Dividend Growth Rate Percentage | 1.72% |
| 3-Year Dividend Growth Rate Percentage | -35.57% |
| 5-Year Dividend Growth Rate Percentage | 1.76% |
| All-Time Dividend Growth Rate Percentage | 16.09% |
| Dividend Payout Ratio | 26.04% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -5.80% |
| Annual Earnings Growth | 0.98% |
| Reported EPS 12 Trailing Months | 4.57 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 4.57 |
| Net Income Twelve Trailing Months | 16,636,000 |
| Net Income Past Year | 16,635,000 |
| Net Income Prior Year | 16,473,000 |
| Quarterly Revenue Growth YOY | -9.10% |
| 5-Year Revenue Growth | 5.04% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 92,868,000 |
| Total Cash Past Year | 92,868,000 |
| Total Cash Prior Year | 75,052,000 |
| Net Cash Position Most Recent Quarter | 92,868,000 |
| Net Cash Position Past Year | 92,868,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 128,313,000 |
| Total Stockholder Equity Prior Year | 114,254,000 |
| Total Stockholder Equity Most Recent Quarter | 128,313,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.73 |
| MACD Signal | -0.66 |
| 20-Day Bollinger Lower Band | 62.01 |
| 20-Day Bollinger Middle Band | 74.54 |
| 20-Day Bollinger Upper Band | 87.08 |
| Beta | 0.13 |
| RSI | 41.98 |
| 50-Day SMA | 83.28 |
| 200-Day SMA | 85.43 |
System |
|
| Modified | 4/25/2024 2:02:58 PM EST |